Finally, ELISA confirmed the association and dysregulation of GLG1 in CRC metastasis, showing GLG1 measurement in plasma of CRC patients and controls diagnostic ability of advanced stages of the disease. The gene discussed is GLG1; the disease is colorectal carcinoma.